Crohn's disease Treatment Market Analysis

  • Report ID: 3004
  • Published Date: Sep 23, 2024
  • Report Format: PDF, PPT

Crohn's disease Treatment Market Analysis

On the basis of type, the crohn's disease treatment market is segmented into Ileocolitis, Ileitis, Granulomatous colitis, Gastroduodenal Crohn's Disease, Jejunoileitis, and Perianal Crohn’s Disease. Out of which, the Ileocolitis segment is anticipated to garner largest share as this is the most common type of Crohn's disease. It causes inflammation of the lower portion of the small intestine, or ileum, and the large intestine, or colon.

On the basis of treatment, the market is segmented into surgical and non-surgical. Out of these two, non-surgical holds the highest share, over the forecast period. Non-surgical is further divided into anti-inflammatory, immune system suppressors, antibiotics, and others. In 2020, the anti-inflammatory segment was the largest segment of the market due to its greater efficacy compared to analgesic and immunosuppressants, while the immune system suppressors segment is expected to be the fastest-growing segment due to the reduction in surgeries and hospitalization rates.

On the basis of end users, the market is segmented into hospitals and clinics, research institutes, and others. The hospitals segment is expected to hold the highest share of the market as a considerable portion of the population with Crohn’s disease on a global level tend to choose healthcare facilities specializing in its treatment.

Our in-depth analysis of the global market includes the following segments:

         By Type

  • Ileocolitis
  • Ileitis
  • Granulomatous colitis
  • Gastroduodenal Crohn’s Disease
  • Jejunoileitis
  • Perianal Crohn’s Disease

                 By Treatment

  • Non-Surgical
  • Surgical

               By End User

  • Hospitals
  • Clinics
  • Research Institutes
  • Others
 

 

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3004
  • Published Date: Sep 23, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing incidence of bowel disorders such as Crohn’s disease due to lifestyle changes and increasing awareness about Crohn’s disease, and the availability of treatments.

The market is anticipated to attain a moderate CAGR over the forecast period, i.e., 2021-2029.

High cost of treatment and delay in diagnosis are estimated to hamper market growth.

The market in Asia Pacific region will provide ample growth opportunities owing to the increasing awareness about chron’s disease.

The major players dominating the chron’s disease treatment market are Pfizer Inc., Allergan, AbbVie Inc., Bayer AG, Amgen Inc., Takeda Pharmaceutical Company Limited, UCB S.A., Ferring B.V., Eli Lilly Company, Hoffman-La Roche, Bristol-Myers Squibb among others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample